Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 12/31/10
Due: 12/31/11
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety and Efficacy Placebo Controlled Study of ATH008 Cream in PPES Patients Secondary to Capecitabine | NCT01316406 | Advancell - Advanced In Vitro Cell Technologies, S.A. | user2@example.com | None | 2011-02-28 | 2013-08-31 | 2014-08-31 | - | - | 2025-07-14 |
| Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients | NCT00559624 | Advancell - Advanced In Vitro Cell Technologies, S.A. | user2@example.com | None | 2007-12-31 | 2010-12-31 | 2011-12-31 | - | - | 2025-07-14 |